SAEC Names New Partners, Launches Stage II | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium (SAEC) announced today four new partners that have joined the initiative as it launches Stage II of its research efforts.

The new partners are the University of Liverpool and Newcastle University — both which were announced as partners earlier this month — the HMO Research Network, and Cerner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.